These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 7919761

  • 21. Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height.
    Lazar L, Pertzelan A, Weintrob N, Phillip M, Kauli R.
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4127-32. PubMed ID: 11549638
    [Abstract] [Full Text] [Related]

  • 22. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
    Roger M, Chaussain JL, Berlier P, Bost M, Canlorbe P, Colle M, Francois R, Garandeau P, Lahlou N, Morel Y.
    J Clin Endocrinol Metab; 1986 Apr; 62(4):670-7. PubMed ID: 2936759
    [Abstract] [Full Text] [Related]

  • 23. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty.
    Clemons RD, Kappy MS, Stuart TE, Perelman AH, Hoekstra FT.
    Am J Dis Child; 1993 Jun; 147(6):653-7. PubMed ID: 8506834
    [Abstract] [Full Text] [Related]

  • 24. Suppression of puberty in girls with short-acting intranasal versus subcutaneous depot GnRH agonist.
    Tuvemo T, Gustafsson J, Proos LA, Swedish Growth Hormone Group.
    Horm Res; 2002 Jun; 57(1-2):27-31. PubMed ID: 12006716
    [Abstract] [Full Text] [Related]

  • 25. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females.
    Bertelloni S, Baroncelli GI, Sorrentino MC, Perri G, Saggese G.
    Eur J Pediatr; 1998 May; 157(5):363-7. PubMed ID: 9625331
    [Abstract] [Full Text] [Related]

  • 26. Combined therapy with GnRH analog plus growth hormone in central precocious puberty.
    Pucarelli I, Segni M, Ortore M, Moretti A, Iannaccone R, Pasquino AM.
    J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():811-20. PubMed ID: 10969926
    [Abstract] [Full Text] [Related]

  • 27. [Long-term experiences with a long-acting gonadotropin releasing hormone analog in therapy of central precocious puberty: effect on body growth].
    Hofmann-Ehrhart B, Schulz U, Kluge M, Wandl-Vergesslich K, Waldhauser F.
    Wien Klin Wochenschr; 1995 Jul; 107(14):413-7. PubMed ID: 7668000
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Diagnosis and treatment of central precocious puberty--can final height be improved? German/Dutch Central Precocious Puberty Study Group.
    Sippell WG.
    Horm Res; 1994 Jul; 41 Suppl 2():14-5. PubMed ID: 8088698
    [Abstract] [Full Text] [Related]

  • 30. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone release hormone (D-Tryp6-GnRH) in monthly injections. Its possible use in normal puberty.
    Marcondes JA, Abujamra AC, Minanni SL, Mendonca BB, Nery M, Lerario AC, Pereira MA, Abelin N, Wajchenberg BL.
    Horm Metab Res; 1993 Feb; 25(2):105-9. PubMed ID: 8458605
    [Abstract] [Full Text] [Related]

  • 31. Treatment of central precocious puberty with triptorelin 11.25 mg depot formulation.
    Martínez-Aguayo A, Hernández MI, Beas F, Iñiguez G, Avila A, Sovino H, Bravo E, Cassorla F.
    J Pediatr Endocrinol Metab; 2006 Aug; 19(8):963-70. PubMed ID: 16995580
    [Abstract] [Full Text] [Related]

  • 32. [Treatment of central precocious puberty with sustained-release triptorelin].
    Boucekkine C, Blumberg-Tick J, Roger M, Thomas F, Chaussain JL.
    Arch Pediatr; 1994 Dec; 1(12):1127-37. PubMed ID: 7849900
    [Abstract] [Full Text] [Related]

  • 33. Effects of luteinizing hormone-releasing hormone agonists on final height in luteinizing hormone-releasing hormone-dependent precocious puberty.
    Oerter KE, Manasco PK, Barnes KM, Jones J, Hill S, Cutler GB.
    Acta Paediatr Suppl; 1993 Mar; 388():62-8; discussion 69. PubMed ID: 8329833
    [No Abstract] [Full Text] [Related]

  • 34. Time to menarche and final height after histrelin implant treatment for central precocious puberty.
    Gillis D, Karavani G, Hirsch HJ, Strich D.
    J Pediatr; 2013 Aug; 163(2):532-6. PubMed ID: 23485026
    [Abstract] [Full Text] [Related]

  • 35. [Growth, development and prediction of body height in children with central precocious puberty after 3 years of therapy with Decapeptyl-Depot, a slow-releasing GnRH agonist].
    Hümmelink R, Oostdijk W, Partsch CJ, Odink RJ, Drop SL, Sippell WG.
    Cesk Pediatr; 1994 Aug; 49(1):7-12. PubMed ID: 8124755
    [Abstract] [Full Text] [Related]

  • 36. Comparative analysis of different puberty inhibiting mechanisms of two GnRH agonists and the GnRH antagonist cetrorelix using a female rat model.
    Roth C, Leonhardt S, Seidel C, Luft H, Wuttke W, Jarry H.
    Pediatr Res; 2000 Oct; 48(4):468-74. PubMed ID: 11004237
    [Abstract] [Full Text] [Related]

  • 37. Triptorelin depot for the treatment of children 2 years and older with central precocious puberty.
    Bertelloni S, Mucaria C, Baroncelli GI, Peroni D.
    Expert Rev Clin Pharmacol; 2018 Jul; 11(7):659-667. PubMed ID: 29957076
    [Abstract] [Full Text] [Related]

  • 38. Impact of 6-month triptorelin formulation on predicted adult height and basal gonadotropin levels in patients with central precocious puberty.
    Yoo E, Kim S, Jung HL, Shim JY, Shim JW, Kim DS, Kwak JH, Kim ES, Yang A.
    Front Endocrinol (Lausanne); 2023 Jul; 14():1134977. PubMed ID: 36875449
    [Abstract] [Full Text] [Related]

  • 39. Two-year results of treatment with depot leuprolide acetate for central precocious puberty.
    Neely EK, Hintz RL, Parker B, Bachrach LK, Cohen P, Olney R, Wilson DM.
    J Pediatr; 1992 Oct; 121(4):634-40. PubMed ID: 1403402
    [Abstract] [Full Text] [Related]

  • 40. The treatment of central precocious puberty using an intranasal LHRH analogue (buserelin).
    Stanhope R, Adams J, Brook CG.
    Clin Endocrinol (Oxf); 1985 Jun; 22(6):795-806. PubMed ID: 3926352
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.